Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of HLB Therapeutics Co.,Ltd.
No Price
Closing Price XKOS 30.04.2026:
3.530,00 KRW
30.04.2026 06:30
Current Prices from HLB Therapeutics Co.,Ltd.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
KOSDAQ
115450.KQ
KRW
30.04.2026 06:30
3.530,00 KRW
-
Share Float & Liquidity
Free Float86,87 %
Shares Float76,58 M
Shares Outstanding88,15 M
Company Profile for HLB Therapeutics Co.,Ltd. Share
HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrical and electronic components, such as motors, pumps, and transformers. The company was formerly known as G-treeBNT Co., Ltd. and changed its name to HLB Therapeutics Co.,Ltd. in December 2021. HLB Therapeutics Co.,Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea.
